PROVIDENCE HEALTH & SERVICES - OREGON

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 16239
 
  
 
C07K PEPTIDES 7129
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 4163
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 297
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 2204
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 198
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 1124

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0021,420 METHODS AND COMPOSITIONS FOR INDUCING AN IMMUNE RESPONSE TO EGFRVIIIOct 02, 17Jan 25, 18[A61K, C07K]
2017/0239,283 USE OF STING AGONISTS TO TREAT VIRALLY-INDUCED AND PRE-MALIGNANT GROWTHSFeb 22, 17Aug 24, 17[A61K]
2017/0216,420 BACTERIAL VACCINES DEFICIENT IN THE 2-C-METHYL-D-ERYTHRITOL-4-PHOSPHATE PATHWAY AND METHODS OF PREPARATION AND USE THEREOFOct 13, 15Aug 03, 17[A61K, C12N]
2017/0202,949 DEFECTIVE RIBOSOMAL PRODUCTS IN BLEBS (DRIBBLES) AND METHODS OF USE TO STIMULATE AN IMMUNE RESPONSEDec 29, 16Jul 20, 17[A61K, C12N, C07K]
2016/0076,109 ALLOGENEIC AUTOPHAGOSOME-ENRICHED COMPOSITION FOR THE TREATMENT OF DISEASENov 25, 15Mar 17, 16[C12Q, G01N]
2015/0157,710 DUAL OX40 AGONIST/IL-2 CANCER THERAPY METHODSMar 02, 12Jun 11, 15[A61K]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9920378 Allogeneic autophagosome-enriched composition for the treatment of diseaseNov 25, 15Mar 20, 18[A61K, C12Q, G01N]
9872909 Method for enhancing specific immunotherapies in cancer treatmentSep 17, 13Jan 23, 18[A61K, C07K]
9828432 Cancer treatment and monitoring methods using OX40 agonistsFeb 06, 12Nov 28, 17[A61K, G01N, C07K]
9775891 Methods and compositions for inducing an immune response to EGFRvIIINov 25, 15Oct 03, 17[C07H, A61K, C07K]
9226955 Allogeneic autophagosome-enriched composition for the treatment of diseaseOct 23, 13Jan 05, 16[A61K, G01N]
9200057 Methods and compositions for inducing an immune response to EGFRvIIINov 17, 11Dec 01, 15[A61K, C12N, C07K]
7959925 Trimeric OX40-immunoglobulin fusion protein and methods of useNov 13, 09Jun 14, 11[A61K, C07H, C12P, C07K]
7622444 Methods for using OX-40 ligand to enhance an antigen specific immune responseSep 29, 06Nov 24, 09[A61K, C07K]
7504101 Methods for enhancing antigen-specific immune response using antibodies that bind OX-40Sep 04, 01Mar 17, 09[A61K, C07K]
6312700 Method for enhancing an antigen specific immune response with OX-40LFeb 23, 99Nov 06, 01[A61K]

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2014/0186,292 DEFECTIVE RIBOSOMAL PRODUCTS IN BLEBS (DRIBBLES) AND METHODS OF USE TO STIMULATE AN IMMUNE RESPONSEAbandonedFeb 10, 14Jul 03, 14[A61K]
2013/0209,502 ALUMINA NANOPARTICLE BIOCONJUGATES AND METHODS OF STIMULATING AN IMMUNE RESPONSE USING SAID BIOCONJUGATESAbandonedAug 26, 11Aug 15, 13[A61K]
2009/0317,407 AUGMENTATION OF IMMUNE RESPONSE TO CANCER VACCINEAbandonedMay 02, 07Dec 24, 09[A61K, A61P]
2006/0280,728 Trimeric OX40-immunoglobulin fusion protein and methods of useAbandonedMay 04, 06Dec 14, 06[A61K, C07H, C12P, C12N, C07K]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.